Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer

Journal of Pathology

Volumn 195, Issue 5, 2001, Pages 543-548

  Gnanasampanthan, G ^a   Elsaleh, H ^a   McCaul, K ^b   Iacopetta, B ^a  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Microsatellite instability; Predictive markers; TP53

Indexed keywords

ASPARTIC ACID; BIOCHEMICAL MARKER; FLUOROURACIL; FOLINIC ACID; GLYCINE; LEVAMISOLE; PROTEIN P53; VALINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CODON; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENDER; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ONCOGENE K RAS; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; TUMOR LOCALIZATION;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ASPARTIC ACID; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; GENES, RAS; HUMANS; MALE; MIDDLE AGED; MUTATION; PATIENT SELECTION; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0035663159     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.990     Document Type: Article

References (23)

1. Ras oncogenes in human cancer: A review
2. Genetic alterations during colorectal tumour development
3. Kirsten ras mutations in patients with colorectal cancer: The multicenter 'RASCAL' study
4. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality
5. Detection of K-ras mutations in lung carcinomas - Relationship to prognosis
6. Structural differences between valine-12 and aspartate-12 ras proteins may modify carcinoma aggression
7. TP53 point mutation and survival in colorectal cancer patients
8. TP53 and long-term prognosis in colorectal cancer: Mutations in the L3 zinc-binding domain predict poor survival
9. The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation
10. Increased resistance to cis-diamminedichloroplatinum(I) in NIH 3T3 cells transformed by ras oncogenes
11. Mutant K-ras oncogenes in colon cancers do not predict patient's chemotherapy response or survival
12. Ki-ras mutation and p53 overexpression predict the clinical behaviour of colorectal cancer: A Southwest Oncology Group study
13. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report
14. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer
15. Ubiquitous somatic mutation in simple repeated sequences reveals a new mechanism for colonic carcinogenesis
16. INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer
17. Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma: Influence of tumour site, stage, adjuvant chemotherapy and type of mutation
18. A rapid and non-isotopic method for the screening and sequencing of TP53 gene mutations in formalin-fixed, paraffin-embedded tumours
19. Methods in laboratory investigation. Rapid and simple detection of c-Ki-ras2 gene codon 12 mutations by non-radioisotopic single-strand conformation polymorphism analysis
20. Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer
21. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer
22. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: Results from four national surgical adjuvant breast and bowel project adjuvant studies (C-01, C-02, C-03, and C-04)
23. Routine analysis of p53 mutation in clinical breast tumour specimens using fluorescence-based polymerase chain reaction and single strand conformation polymorphism